Researchers will use Cellply's VivaCyte platform to conduct single-cell analyses of NK cells and evaluate their ability to treat the bone marrow cancer.

First part of a 2-part interview with Stephen Strickland, MD, MSCI, director of leukemia research for Sarah Cannon Research ...

As more and more dream products promise results by morning, it’s time for some beauty sleep – but not as you know it, says ...

Formulated with Augustinus Bader's skin cell-renewing TFC8 technology, it works to leave the skin perfectly primed for makeup, yet radiant enough to wear none at all. It also contains a combination of ...

In addition, patients with AML often have dysfunctional T-cells, which can make it tough to engineer them properly. The new treatment is called CAR NK-cell therapy because it relies on natural killer ...

Happy to spend a little more? Space NK's Everything Shower Edit is £70 and includes brands like Alpha-H, Sol De Janeiro, Living Proof and Aromatherapy Associates. Covering all bases, the contents ...

A high-resolution map of how protein organization inside the cell provides a platform for interrogating the way cancer mutations disrupt entire protein assemblies—not just individual genes. By ...

Long-term treatment with hydroxyurea reduces emergency department visits and days spent in the hospital for children with sickle cell anemia, the most common and usually the most severe form of sickle ...

Sanofi is handing back a phase 2-stage natural killer (NK) cell engager and canceling another cancer trial as the Big Pharma refocuses its relationship with Innate Pharma from oncology to ...

Findings of a research project carried out by the Sickle Cell Society into sickle cell patients’ experiences of ambulance care and 999 and 111 calls in London, revealed that many patients had ...

and chimeric antigen receptor natural killer cell (CAR-NK) therapy research and development. This antibody is said to target a tumour antigen prevalent in several major solid cancers such as ...

OT-C001 is an allogeneic cell therapy of highly activated and expanded NK cells from UCB, manufactured using a patented expansion and activation process. It targets tumor cells through direct and ...